outbrain
Close  

Scientists in Germany improve malaria drug production

/ 06:03 PM February 22, 2018

In this Feb. 1, 2012 file photo, Prof. Peter Seeberger, a former Massachusetts Institute of Technology professor poses with a molecule model at his laboratory in Berlin, Germany. Scientists in Germany who developed a new way to make a key malaria drug several years ago said Wednesday Feb. 21, 2018 they have come up with a technique to make the process even more efficient, which should increase global access and reduce the cost. “This development has the potentiation to save millions of lives by increasing the global access and reducing the cost of anti-malaria medicine,” Peter Seeberger, director of the Max Planck Institute unit working on the issue. (AP Photo/Markus Schreiber,file)

BERLIN — Scientists in Germany who developed a new way to make a key malaria drug several years ago said Wednesday they have come up with a technique to make the process even more efficient, which should increase global access and reduce the cost.

The new procedure refines a method developed in 2012 at the Max Planck Institute to use the waste product from the production of artemisinin, which is extracted from a plant known as sweet wormwood, to produce the drug itself. That involved a new machine that could convert about 40 percent of the waste acid into artemisinin itself, producing more of the drug from what had in the past been discarded.

ADVERTISEMENT

The new procedure uses the plant’s own chlorophyll instead of additional chemicals as catalysts to drive the reaction, directly using the crude materials to produce the drug more efficiently, chemist Kerry Gilmore said.
“We’re able to get much more out of the plant than ever before,” he said. “The process we have now is more efficient and significantly cheaper than what we had in 2012.”

The World Health Organization reported in November that there were 216 million malaria cases worldwide in 2016, up 5 million over 2015, and 445,000 people died of the disease, primarily children. Artemisinin-based therapies are considered the best treatment, but often cost far too much for many of the impoverished communities worst hit by malaria.

FEATURED STORIES

“This development has the potentiation to save millions of lives by increasing the global access and reducing the cost of anti-malaria medicine,” Peter Seeberger, director of the Max Planck Institute unit working on the issue.

The researchers are working with the U.S. state of Kentucky on a pilot project to start an operation where sweet wormwood is cultivated on thousands of acres and then processed on site into the anti-malaria drug. The target is to have it operational in three years, Gilmore said.”We will have the entire supply chain under one roof, going from plants to pill,” he said. MKH

RELATED STORIES: 

Malaria spread sends health execs to Palawan

Malaria deaths fall 60 percent since 2000—UN

ADVERTISEMENT
TOPICS: Germany, Malaria, Max Planck Institute
Read Next
EDITORS' PICK
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.